Mechanism of action studies performed in vitro and on mouse tumor samples suggest that the combination PIM-Pd inhibits protein translation processes through the convergent inhibition of c-Myc and mTORC1, which subsequently disrupts the function of eIF4E. This evidence concerns the gene PIM1 and neoplasm.